Authors
Loading...
May support targeted genetic testing in ARVC; leaves open validation of plakoglobin loss as a diagnostic marker.
Key points are not available for this paper at this time.
Gehmlich et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: